JPS54126731A - Carcinostatic agent - Google Patents

Carcinostatic agent

Info

Publication number
JPS54126731A
JPS54126731A JP3200878A JP3200878A JPS54126731A JP S54126731 A JPS54126731 A JP S54126731A JP 3200878 A JP3200878 A JP 3200878A JP 3200878 A JP3200878 A JP 3200878A JP S54126731 A JPS54126731 A JP S54126731A
Authority
JP
Japan
Prior art keywords
effective component
hydroxy
carcinostatic agent
benzaldehyde derivative
parenteral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3200878A
Other languages
English (en)
Other versions
JPS6334124B2 (ja
Inventor
Setsuo Takeuchi
Mutsuyuki Kochi
Akira Kawarada
Shinichiro Esumi
Kazuya Sasaki
Shozo Kawabata
Tsuneo Saida
Yukio Inoue
Tadasu Yamamoto
Takaharu Sekine
Koji Amamiya
Katsumasa Saga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
RIKEN Institute of Physical and Chemical Research
Original Assignee
Kaken Pharmaceutical Co Ltd
Kaken Chemical Co Ltd
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd, Kaken Chemical Co Ltd, RIKEN Institute of Physical and Chemical Research filed Critical Kaken Pharmaceutical Co Ltd
Priority to JP3200878A priority Critical patent/JPS54126731A/ja
Publication of JPS54126731A publication Critical patent/JPS54126731A/ja
Publication of JPS6334124B2 publication Critical patent/JPS6334124B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP3200878A 1978-03-20 1978-03-20 Carcinostatic agent Granted JPS54126731A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3200878A JPS54126731A (en) 1978-03-20 1978-03-20 Carcinostatic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3200878A JPS54126731A (en) 1978-03-20 1978-03-20 Carcinostatic agent

Publications (2)

Publication Number Publication Date
JPS54126731A true JPS54126731A (en) 1979-10-02
JPS6334124B2 JPS6334124B2 (ja) 1988-07-08

Family

ID=12346836

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3200878A Granted JPS54126731A (en) 1978-03-20 1978-03-20 Carcinostatic agent

Country Status (1)

Country Link
JP (1) JPS54126731A (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
WO1994007479A2 (en) * 1992-10-01 1994-04-14 The Wellcome Foundation Limited Immunopotentiatory agents
JPWO2013187069A1 (ja) * 2012-06-15 2016-02-04 国立大学法人金沢大学 Ｐｄｔ効果増強剤
JP2017531689A (ja) * 2014-10-21 2017-10-26 イオン、ファーマシューティカル、エス．アー エル．エル．Ｉｏｎｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｓ．Ａ Ｒ．Ｌ． ヒト治療薬

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
WO1994007479A2 (en) * 1992-10-01 1994-04-14 The Wellcome Foundation Limited Immunopotentiatory agents
WO1994007479A3 (en) * 1992-10-01 1994-07-21 Wellcome Found Immunopotentiatory agents
JPWO2013187069A1 (ja) * 2012-06-15 2016-02-04 国立大学法人金沢大学 Ｐｄｔ効果増強剤
JP2017531689A (ja) * 2014-10-21 2017-10-26 イオン、ファーマシューティカル、エス．アー エル．エル．Ｉｏｎｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｓ．Ａ Ｒ．Ｌ． ヒト治療薬

Also Published As

Publication number Publication date
JPS6334124B2 (ja) 1988-07-08

Similar Documents

Publication Publication Date Title
MY102980A (en) Transdermal flux enhancing compositions
JPS54126731A (en) Carcinostatic agent
JPS5767516A (en) Novel analgesic agent
JPS5489036A (en) Remedy and preventive for hypersensitivity to light
JPS5551018A (en) Carcinostatic agent
JPS5470428A (en) Carcinostatic agent
KIMURA et al. Chemical structural requirement in gingerol derivatives for potentiation of prostaglandin F2α-induced contraction in isolated mesenteric veins of mice
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
JPS54132239A (en) Anti-tumor agent
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS6434913A (en) Antitumor agent
JPS5545656A (en) Carcinostatic agent
JPS5569510A (en) Carcinostatic agent
JPS54126733A (en) Carcinostatic agent
JPS5695114A (en) Carcinostatic agent
JPS5394012A (en) Novel polysaccharide and its preparation
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS54125627A (en) Carcinostatic and novel compound having carcinostatic property
JPS57156412A (en) Preparation containing dextromethorphan hydrobromide
JPS5639019A (en) Antiviral agent
JPS5742620A (en) Novel antiulcer agent
JPS5780317A (en) Preparation of pharmaceutical composition for injection
JPS56115716A (en) Immuno-chemotherapeutic, drug resistance preventing, carcinostatic agent
JPS5569569A (en) Carcinostatic
JPS5675432A (en) Antitumor agent containing ethyl piperidylacetylaminobenzoate